24 January 2022: Articles
A 63-Year-Old Man with a Diagnosis of Re-Infection with SARS-CoV-2 Nine Weeks After an Initial Hospital Admission with COVID-19 Pneumonia
Unusual clinical course, Challenging differential diagnosis, Management of emergency care, Educational Purpose (only if useful for a systematic review or synthesis)
Ilona Dudek A , Marzena Jesiotr B , Agnieszka Rzeszotarska D , Krzysztof Kłos B , Andrzej Chciałowski D , Monika Nowak B , Jolanta Korsak C*DOI: 10.12659/AJCR.932999
Am J Case Rep 2022; 23:e932999
Table 1. Results of laboratory tests, clinical indicators and treatment. Included empirical antibiotic therapy, recombinant human granulocyte growth factor and Covid-19 therapy in line with the WHO recommendations for clinical management of COVID-19 at that time (May 18, 2020).
| Department of Infectious Diseases | Home | Department of Pulmonology | Department of Infectious Diseases | ICU | |||||
|---|---|---|---|---|---|---|---|---|---|
| Week | I | II/III | IV/VII | I | II | I | II | III | |
| WBC (×10/l) | 0.95 | 3.03 | 5.59 | – | 7.50 | 7.36 | 6.00 | 4.42 | 7.13 |
| Lymphocytes (×10/l) | 0.30 | 1.18 | 2.35 | – | 0.63 | 0.58 | 0.29 | 0.19 | 1.93 |
| Granulocytes (×10/l) | 0.40 | 1.35 | 2.32 | – | 6.15 | 6.43 | 5.30 | 4.15 | 4.10 |
| Plateets (×10/l) | 120 | 154 | 206 | – | 199 | 270 | 202 | 153 | 302 |
| Procalcitonine (ng/ml) | 1.01 | – | 0.22 | 0.11 | 0.16 | 0.22 | 0.26 | ||
| CRP (mg/dl) | 4.5 | 0.1 | 0.1 | – | 14.29 | 1.4 | 14.3 | – | – |
| D-dimers (g/ml) | – | – | – | – | – | – | 0.58 | – | – |
| ALT U/l | 28 | 24 | 30 | 103 | 129 | 73 | 65 | 48 | |
| IL-6 | 0.00 | 2.19 | 3.37 | 162.00 | 6.50 | ||||
| RNA SARS-CoV-2 | (+) | (+) | 2×(−) | 4×(−) | (−) | (−) | 2× (+) | +/− | 2×(−) |
| SARS-CoV-2 IgM (Index >6 positive) | 10.50 | 10.92 7.95 | 5.01 | 5.7 | >40 | ||||
| SARS-CoV-2 IgG (Index >8 positive) | 1.28 | 1.73 1.30 | 1.27 | 1.9 | >40 | ||||
| Sat.O2 (n>92%) lowest measured value | 93 | 93/96 | 95/97 | – | 94 | 95 | 85 | O2 therapy opti-flow | 94 |
| Pharmacotherapy | Filgastrim, Chloroquine, Azithromycin, Lopinavir/Rytonavir Ceftazidime | Ciprofloxacin, Ceftriaxone, Amikacine, clarithomycin, Fluconazole, Piperacillin/Tazobactam | Dexametasone, Fluconazole, Clindamycin, Gentamicin, Vancomycin, Nadroparin | Plasma of convalescents, Meropenem, Dexametasone, Nadroparin | |||||